过刊浏览

血红素氧合酶--1／一氧化碳通路参与辛伐他汀抗高血压诱发的大鼠心肌肥厚

姚海木, 吴学思, 张靖, 耿彬, 唐朝枢

首都医科大学附属北京安贞医院心内科.北京 100029；北京大学医学部生理与病理生理学系.北京 100083

摘要

为了探讨他汀类药物抑制心肌肥厚的作用机制，该研究应用一氧化氮合酶抑制剂左旋硝基精氨酸[N--nitro--L--arginine，L--NNA，15mg／（kg·d）]制备大鼠高血压心肌肥厚模型，并分别给予不同剂量辛伐他汀[5或30mg／（kg·d）]进行干预。6周后测大鼠左心室功能、左心室重量指数（left ventricular mass index，LVMI）、心肌脑钠素（brain natriuretic peptide，BNP）含量、心肌羟脯氨酸含量和心肌血红素氧合酶（heme oxygenase，HO）活性。在体外培养的新生大鼠心肌细胞中，观察辛伐他汀对血管紧张素Ⅱ（angiotensinⅡ，AngⅡ）引起的心肌细胞肥大的抑制作用与细胞血红素氧合酶--1（HO--1）表达、HO活性及CO生成间的关系。结果表明，辛伐他汀干预明显减轻L--NNA处理大鼠的心肌肥厚（LVMI值、心肌BNP和羟脯氨酸含量均显著低于单纯L--NNA处理组），改善左心室舒张功能，而且心肌HO活性显著升高。在离体培养的原代乳鼠心肌细胞，辛伐他汀浓度依赖性地抑制AngⅡ引起的细胞肥大（~(3)H--亮氨酸掺入），并相应增加HO--1 mRNA表达、HO活性和CO生成量。应用HO抑制剂锌卟啉能有效抑制辛伐他汀抗AngⅡ诱导的心肌肥大作用。结果提示：辛伐他汀上调HO--1／CO通路是其抗高血压诱发的心肌肥厚的机制之一。

关键词： 辛伐他汀; 心肌肥厚; 血红素氧合酶

Simvastatin inhibits hypertension--induced cardiac hypertrophy in rats through activation of heme oxygenase--1/carbon monoxide pathway

Yao Haimu, Wu Xuesi, Zhang Jing, Geng Bin, Tang Chaoshu

Department of Cardiology, Beijing Anzhen Hospital, Capital University of Medical Science.Beijing 100029；China

Abstract

To investigate the anti-cardiac hypertrophic mechanism of statins, thirty-eight male Wistar rats were randomly allocated to four groups. Rats in model group received nitric oxide synthase inhibitor, N-nitro-L-arginine （L-NNA） 15 mg/（kg·d） by peritoneal injection. Rats in simvastatin treatment groups were given simultaneously L-NNA as those in model group and simvastatin 5 or 30 mg/ （kg·d） intragastrically respectively. Rats in control group received the same volume of normal sodium. Left ventricular function, left ventricular mass index （LVMI）, the content of brain natriuretic peptide （BNP） in plasma and myocardium, myocardial hydroxyproline and heme oxygenase activity were determined after 6 weeks. The results showed that rats in model group developed significant cardiac hypertrophy associated with reduced left ventricular function compared with the control group. However, compared with the model group, L-NNA-induced cardiac hypertrophy of rats was significantly relieved in simvastatin treatment groups, associated with improved left ventricular function, decreased LVMI, lower BNP levels in plasma and myocardium, lower content of myocardial hydroxyproline, and increased myocardial heme oxygenase （HO） activity. In cultured rat neonatal cardiomyocytes, simvastatin （30 or 100μmol/L） significantly increased heme oxygenase-1 （HO-1） mRNA expression, HO activity as well as the production of CO in cardiomyocytes. Cultured with zinc protoporphyrin, a HO inhibitor, or simvastatin alone did not change [~(3)H]leucine uptake of cardiomyocytes. However, cocultured with simvastatin significantly inhibited the cardiomyocyte [3H]leucine uptake induced by angiotensin Ⅱ in a concentration- dependent manner. Cotreatment with zinc protoporphyrin significantly abolished the suppressive effect of simvastatin on cardiomyocyte [^3H]leucine uptake. These data suggest that the activation of HO-1/CO pathway may be one of the important mechanisms by which statins inhibit cardiac hypertrophy caused by hypertension.

Key words: simvastatin;Cardiac hypertrophy;heme oxygenase

收稿日期：　　录用日期：

通讯作者：　　E-mail:

引用本文：

姚海木, 吴学思, 张靖, 耿彬, 唐朝枢. 血红素氧合酶--1／一氧化碳通路参与辛伐他汀抗高血压诱发的大鼠心肌肥厚[J]. 生理学报 2006; 58 (2): .

Yao Haimu, Wu Xuesi, Zhang Jing, Geng Bin, Tang Chaoshu. Simvastatin inhibits hypertension--induced cardiac hypertrophy in rats through activation of heme oxygenase--1/carbon monoxide pathway. Acta Physiol Sin 2006; 58 (2): (in Chinese with English abstract).